XMTR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
XMTR is not a clear buy right now for a beginner long-term investor, despite constructive fundamentals and bullish analyst sentiment. The stock is trading near resistance after a strong run, and the options/candlestick data suggest limited near-term upside. If you want to act immediately with $50,000-$100,000, the better move is to hold and wait for a cleaner entry rather than buy at current levels.
XMTR's price trend is bullish overall: SMA_5 > SMA_20 > SMA_200, which confirms a strong uptrend. MACD histogram remains positive at 0.903, but it is contracting, indicating momentum is slowing. RSI_6 at 66.138 is near overbought territory but not extreme. The current price of 88.22 is above the pivot at 86.051 and below resistance 1 at 91.779, so the stock is approaching a short-term ceiling. With the pattern-based outlook showing a 70% chance of weakness over the next day/week/month, the technical setup is not ideal for an impatient buyer.
Recent analyst upgrades and higher price targets are a major positive. Citi raised its target to $98 and keeps Buy; Citizens raised to $100 and keeps Outperform; RBC raised to $85 after a strong beat-and-raise quarter; Goldman lifted its target to $78 while acknowledging continued marketplace strength; Cantor upgraded to Overweight. News flow is also supportive: Xometry appointed AI expert Lukas Biewald to its board, and the Siemens partnership could expand distribution, accelerate growth, and improve long-term profitability. Trading sentiment in options is also constructive, favoring calls over puts.
The stock is near resistance after a strong move, and momentum is starting to fade as the MACD histogram contracts. The pattern-based trend estimate points to downside over the next day, week, and month. Insider and hedge fund activity is neutral, so there is no strong confirmation from smart-money flows. No recent congress trading data is available. The AI Stock Picker and SwingMax signals are both absent, so there is no proprietary signal-backed entry today.
Latest quarter: Q1 2026. The financial backdrop appears strong based on analyst commentary: revenue accelerated for the third consecutive quarter, Q1 results beat expectations, full-year growth guidance improved, and adjusted EBITDA was positive for a sixth consecutive quarter. Goldman and RBC both highlighted marketplace strength and improved profitability trends. Although the full financial snapshot was unavailable, the latest quarter clearly showed accelerating growth and improving operating leverage.
Analyst sentiment is positive and improving. Recent actions include multiple target increases and several bullish ratings: Citi Buy to $98, Citizens Outperform to $100, Cantor Overweight, Wedbush Outperform, RBC Sector Perform with a higher target, Goldman Neutral with a higher target. The bull case centers on marketplace growth, the Siemens partnership, and improved profitability. The bear case is that some firms remain Neutral/Sector Perform, suggesting the Street sees upside but not a universally compelling valuation case at current levels.
